Clinical trial

Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children…

NCT00238927 · McGill University Health Centre/Research Institute of the McGill University Health Centre, Other · Completed

Key facts

NCT number NCT00238927
Title Clinical Trial of Fluticasone Versus Placebo at the Onset of a Cold for Children With Asthma
Official title Multicenter Randomised Controlled Trial of Episodic Fluticasone Versus Placebo in Viral-induced Asthma in Children
Lead sponsor McGill University Health Centre/Research Institute of the McGill University Health Centre, Other
Collaborators Medical Research Council of Canada
Status Completed
Phase Phase 4
Study type Interventional
Conditions Asthma
Intervention type Drug
Interventions inhaled fluticasone 750 mcg/day twice daily until 2 days without symptoms (maximum 15 consecutive days)
Enrollment 150
Start date Nov 1, 1999
Primary completion Sep 1, 2005
Completion Sep 1, 2005
First posted Oct 14, 2005
Last update posted Mar 27, 2014
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies